Headinvest, LLC Novartis Ag Transaction History

Headinvest, LLC

$470 Million
Q4 2023

A detailed history of Headinvest, LLC transactions in Novartis Ag stock. As of the latest transaction made, Headinvest, LLC holds 18,015 shares of NVS stock, worth $1.95 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

18,015

Previous 18,103 0.49%

Holding current value

$1.95 Million

Previous $1.84 Million 1.36%

% of portfolio

0.39%

Previous 0.41%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$92.27 - $101.54 $8,119 - $8,935	-88 Reduced 0.49%	18,015 $1.82 Million
Q2 2023 Aug 23, 2023	SELL	$92.52 - $104.91 $50,238 - $56,966	-543 Reduced 2.91%	18,103 $1.83 Million
Q1 2023 May 17, 2023	SELL	$80.03 - $92.81 $9,843 - $11,415	-123 Reduced 0.66%	18,646 $1.72 Million
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $14,807 - $18,133	-196 Reduced 1.03%	18,769 $1.7 Million
Q3 2022 Dec 28, 2022	SELL	$74.61 - $87.26 $25,740 - $30,104	-345 Reduced 1.79%	18,965 $1.44 Million

Q2 2022 Aug 12, 2022	BUY	$80.52 - $93.75 $91,390 - $106,406	1,135 Added 6.24%	19,310 $1.63 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $16,742 - $18,939	209 Added 1.16%	18,175 $1.6 Million
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $234,318 - $259,102	2,940 Added 19.57%	17,966 $1.57 Million
Q3 2021 Nov 16, 2021	SELL	$81.78 - $95.14 $5,152 - $5,993	-63 Reduced 0.42%	15,026 $1.23 Million
Q2 2021 Aug 30, 2021	BUY	$85.24 - $94.15 $16,962 - $18,735	199 Added 1.34%	15,089 $1.38 Million
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $170,173 - $200,681	2,038 Added 15.86%	14,890 $1.27 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $143,961 - $174,128	1,844 Added 14.35%	14,696 $1.39 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $143,961 - $174,128	-1,844 Reduced 12.55%	12,852 $1.12 Million
Q3 2020 Nov 24, 2020	SELL	$82.14 - $91.0 $8,214 - $9,100	-100 Reduced 0.77%	12,852 $1.12 Million
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $485 - $546	-6 Reduced 0.05%	12,952 $1.13 Million
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $56,818 - $79,604	-804 Reduced 5.84%	12,958 $1.07 Million
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $71,376 - $100,000	1,010 Added 7.92%	13,762 $1.13 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $12,652 - $14,305	-150 Reduced 1.16%	12,752 $1.21 Million
Q3 2019 Nov 21, 2019	SELL	$85.54 - $94.26 $73,564 - $81,063	-860 Reduced 6.25%	12,902 $1.12 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $1.13 Million - $1.29 Million	-14,984 Reduced 52.13%	13,762 $1.32 Million
Q4 2018 Feb 22, 2019	BUY	$73.66 - $82.02 $1.06 Million - $1.18 Million	14,373 Added 100.0%	28,746 $2.47 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $18,408 - $21,293	275 Added 1.95%	14,373 $1.24 Million
Q2 2018 Aug 09, 2018	BUY	$64.91 - $73.36 $6,036 - $6,822	93 Added 0.66%	14,098 $1.07 Million
Q1 2018 Apr 09, 2018	SELL	$70.39 - $84.15 $21,117 - $25,245	-300 Reduced 2.1%	14,005 $1.13 Million
Q4 2017 Jan 30, 2018	SELL	$72.33 - $77.64 $12,296 - $13,198	-170 Reduced 1.17%	14,305 $1.2 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $1.07 Million - $1.12 Million	14,475	14,475 $1.2 Million

Others Institutions Holding NVS

# of Institutions

1,350

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $233B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.

Account